Matching slides 110,471
Current window 78,781-78,810
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all

Component

78,781-78,810 of 110,471

filter-aware
64
The slide uses a stacked bar chart to illustrate revenue composition and CAGR trends.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Financials1 hit
82
Uses a visual bridge/arrow to connect drivers to market growth.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
83
The diagram illustrates a value chain or operational model from data collection to customer delivery.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
85
Slide provides a structured breakdown of business segments with associated KPIs and competitive landscape.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
86
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
87
The diagram uses a hub-and-spoke/process hybrid to link lifecycle stages to specific risk domains and product brands.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
90
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
91
The slide uses a vertical flow diagram to show how partnerships contribute to different layers of the business.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
93
The chart shows a trend line with +11% CAGR.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
95
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
97
The diagram uses a process flow structure to show how various data sources are transformed into usable business assets.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
99
The slide uses a matrix-like structure to map distribution channels to product solutions.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
05
The slide uses a split-layout comparing the company's mission/context on the left with the specific product value proposition and market statistics on the right.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · Problem1 hit
08
Includes a comparison to Exact Sciences' ColoGuard as a market positioning anchor.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · Solution1 hit
10
Includes logos of four partner organizations.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
11
The slide uses a bulleted list to detail the partnership strategy, focusing on leveraging existing lab infrastructure to minimize marketing overhead.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
12
Includes a map of the US and Europe with color-coded status indicators.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
13
Includes a stock market snapshot of Exact Sciences and a clinical performance comparison table.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
14
Includes a disclaimer at the bottom and a product visualization.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
16
The slide lists four key executives: CEO, CFO, COO, and CSO.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
18
Mainz Biomed NV | Investor Presentation Deck | 23 slidesMainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
20
The slide serves as a repository for additional information, specifically partner logos and team representation.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
22
Mainz Biomed NV | Investor Presentation Deck | 23 slidesMainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
03
This is a standard IPO deal term sheet slide.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
05
Uses a Venn diagram to illustrate the intersection of two critical clinical challenges.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Solution1 hit
14
The slide uses a medical illustration to map specific TRK receptor inhibition (TRKB, TRKC, TRKA) to corresponding neurological and physiological side effects.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Competition1 hit
19
The kinome tree is a standard visualization in pharmacology for kinase selectivity.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
20
The slide highlights CNS activity via brain penetration, a key component of the NVL-520 target product profile.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
25
The slide uses a three-column process flow to explain the biological mechanism of ALK-driven cancer and resistance.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
33
Includes disclaimer regarding clinical studies and FDA feedback.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit